Assessing the Quality of Reporting of Observational Studies in Cancer

Annals of Epidemiology

Volumn 20, Issue 1, 2010, Pages 67-73

  Papathanasiou, Afroditi A ^a   Zintzaras, Elias ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Cancer; Epidemiology; Methodology; Observational Study; Quality; STROBE

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; MEDICAL LITERATURE; METHODOLOGY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL;

DOCUMENTATION; EPIDEMIOLOGIC STUDIES; HUMANS; NEOPLASMS; OBSERVATION; QUALITY CONTROL; REVIEW LITERATURE AS TOPIC;

EID: 71549122578     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2009.09.007     Document Type: Article

References (26)

1. Glasziou P., Vandenbroucke J.P., and Chalmers I. Assessing the quality of research. BMJ 328 (2004) 39-41
2. Kunz R. Randomized trials and observational studies: still mostly similar results, still crucial differences. J Clin Epidemiol 61 (2008) 207-208
3. Vandenbroucke J.P. Strega, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK. and CONSORT: for whom does the guideline toll?. J Clin Epidemiol 62 (2009) 594-596
4. Nijsten T., Spuls P., and Stern R.S. STROBE: a beacon for observational studies. Arch Dermatol 144 (2008) 1200-1204
5. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., and Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370 (2007) 1453-1457
6. Vandenbroucke J.P., von Elm E., Altman D.G., Gotzsche P.C., Mulrow C.D., Pocock S.J., et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 4 (2007) e297
7. Knottnerus A., and Tugwell P. STROBE- a checklist to strengthen the reporting of observational studies in Epidemiology. J Clin Epidemiol 61 (2008) 393
8. Ziogas D.C., and Zintzaras E. Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement. Ann Epidemiol 19 (2009) 494-500
9. Groenwold R.H., Van Deursen A.M., Hoes A.W., and Hak E. Poor quality of reporting confounding bias in observational intervention studies: a systematic review. Ann Epidemiol 18 (2008) 746-751
10. Scales Jr. C.D., and Dahm P. The critical use of population-based medical databases for prostate cancer research. Curr Opin Urol 18 (2008) 320-325
11. Bekkering G.E., Harris R.J., Thomas S., Mayer A.M., Beynon R., Ness A.R., et al. How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis?. Am J Epidemiol 167 (2008) 1017-1026
12. Renehan A.G., Tyson M., Egger M., Heller R.F., and Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371 (2008) 569-578
13. Huncharek M., Muscat J., and Kupelnick B. Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: a meta-analysis of 26,769 cases from 45 observational studies. Nutr Cancer 60 (2008) 421-441
14. Bonovas S., Filioussi K., and Sitaras N.M. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies. Int J Cancer 123 (2008) 899-904
15. Tong J.L., Ran Z.H., Shen J., Fan G.Q., and Xiao S.D. Association between fecal bile acids and colorectal cancer: a meta-analysis of observational studies. Yonsei Med J 49 (2008) 792-803
16. Mangiapane S., Blettner M., and Schlattmann P. Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005. Pharmacoepidemiol Drug Saf 17 (2008) 115-124
17. Fabi A., Metro G., Ferretti G., Giannarelli D., Di Cosimo S., Papaldo P., et al. Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studies. Breast 17 (2008) 499-505
18. Bravi F., Scotti L., Bosetti C., Gallus S., Negri E., La Vecchia C., et al. Coffee drinking and endometrial cancer risk: a metaanalysis of observational studies. Am J Obstet Gynecol 200 (2009) 130-135
19. Fung A.E., Palanki R., Bakri S.J., Depperschmidt E., and Gibson A. Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies. Ophthalmology 116 (2009) 286-296
20. Orriols L., Salmi L.R., Philip P., Moore N., Delorme B., Castot A., et al. The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf 18 (2009) 647-658
21. Olmos M., Antelo M., Vazquez H., Smecuol E., Maurino E., and Bai J.C. Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis 40 (2008) 46-53
22. Freedman N.D., Leitzmann M.F., Hollenbeck A.R., Schatzkin A., and Abnet C.C. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol 9 (2008) 649-656
23. Balk E.M., Bonis P.A., Moskowitz H., Schmid C.H., Ioannidis J.P., Wang C., et al. Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA 287 (2002) 2973-2982
24. Moher D., Jones A., and Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 285 (2001) 1992-1995
25. Kane R.L., Wang J., and Garrard J. Reporting in randomized clinical trials improved after adoption of the CONSORT statement. J Clin Epidemiol 60 (2007) 241-249
26. Smidt N., Rutjes A.W., van der Windt D.A., Ostelo R.W., Bossuyt P.M., Reitsma J.B., et al. The quality of diagnostic accuracy studies since the STARD statement: has it improved?. Neurology 67 (2006) 792-797